Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02562040 · ClinicalTrials.gov registry record · NA
Pediatric Adenotonsillectomy Trial for Snoring
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 459
- Enrollment target
NCT02562040: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT02562040 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 459 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02562040, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 459 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of early adenotonsillectomy (eAT) on the behavior, sleep-disordered breathing symptoms and quality of life for children who snore, but do not have obstructive sleep apnea, as well as identify factors that moderate responses to the surgery. Half of participants will receive eAT, while the other half will be observed with watchful waiting and supportive care.
Primary Outcome
The BRIEF GEC section comprises summary measures of behavioral regulation, emotion regulation, and cognitive regulation (BRIEF-2, for children aged 5 to 18 years) or inhibitory self-control, flexibility, and emergent metacognition (BRIEF-P, for preschool-aged children). These scores are linear transformations of the raw scores (mean = 50, sd = 10) where a higher T score indicates a child has a lower capacity to organize and self-regulate.
Interventions
- PROCEDURE Early Adenotonsillectomy (eAT)
- BEHAVIORAL Watchful Waiting with Supportive Care (WWSC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 459 participants |
| Start Date | 2017-06-06 |
| Est. Completion | 2022-02-28 |
| Phase | NA |
What the finished NCT02562040 record still lists
NCT02562040 is an interventional study that assigns participants to a tested intervention. The registered 459 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 2 interventions - of which Early Adenotonsillectomy (eAT) is the first listed.
NCT02562040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02562040 about?
NCT02562040 is a clinical study titled "Pediatric Adenotonsillectomy Trial for Snoring". The purpose of this study is to evaluate the effects of early adenotonsillectomy (eAT) on the behavior, sleep-disordered breathing symptoms and quality of life for children who snore, but do not have obstructive sleep apnea, as well as identify factors that moderate responses to the surgery. Half of...
What is the current status of trial NCT02562040?
This trial is currently completed. It is a NA study. The enrollment target is 459 participants. The study started on 2017-06-06. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT02562040?
The interventions under investigation include: Early Adenotonsillectomy (eAT) (PROCEDURE), Watchful Waiting with Supportive Care (WWSC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02562040?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02562040's enrollment target sits among peer trials
459 224th of 2000 higher than 1,777 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04452825 · 459 participants · NA
A New Psychotherapy Intervention for Older Cancer Patients
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- NCT03427736 · 460 participants
Anesthetics and Analgesics in Children
- NCT03819933 · 460 participants · NA
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI